Mutational status of IgVH genes in B-cell chronic lymphocytic leukemia and prognosis: percent mutations or antigen-driven selection?
- 9 June 2005
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 19 (8), 1490-1492
- https://doi.org/10.1038/sj.leu.2403830
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Analysis of VH gene sequences using two web-based immunogenetics resources gives different results, but the affinity maturation status of chronic lymphocytic leukaemia clones as assessed from either of the resulting data sets has no prognostic significanceLeukemia, 2005
- Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 geneBlood, 2005
- Analysis of IgVH gene mutations in B cell chronic lymphocytic leukaemia according to antigen-driven selection identifies subgroups with different prognosis and usage of the canonical somatic hypermutation machineryBritish Journal of Haematology, 2004
- Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLLBlood, 2004
- VH3-21 Gene Usage in Chronic Lymphocytic Leukemia – Characterization of a New Subgroup with Distinct Molecular Features and Poor SurvivalLeukemia & Lymphoma, 2004
- Chronic Lymphocytic Leukemia B Cells Can Undergo Somatic Hypermutation and Intraclonal Immunoglobulin VHDJH Gene DiversificationThe Journal of Experimental Medicine, 2002
- V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemiaBlood, 2002
- Analysis of the targeting of the hypermutational machinery and the impact of subsequent selection on the distribution of nucleotide changes in human V rearrangementsImmunological Reviews, 1998